Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy
Doxorubicin (DOX) is one of the most effective chemotherapy agents used in the treatment of hematological and solid tumors, however, it causes dose-related cardiotoxicity that may lead to heart failure in patients. One of the major reasons was increased reactive oxygen species (ROS) production. Gins...
Saved in:
Main Authors: | Lan Li (Author), Jingyu Ni (Author), Min Li (Author), Jingrui Chen (Author), Lifeng Han (Author), Yan Zhu (Author), Deling Kong (Author), Jingyuan Mao (Author), Yi Wang (Author), Boli Zhang (Author), Meifeng Zhu (Author), Xiumei Gao (Author), Guanwei Fan (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mass Production of Rg1-Loaded Small Extracellular Vesicles Using a 3D Bioreactor System for Enhanced Cardioprotective Efficacy of Doxorubicin-Induced Cardiotoxicity
by: Yunfeng Di, et al.
Published: (2024) -
Relationship Between Ginsenoside Rg3 and Metabolic Syndrome
by: Hyunji Lee, et al.
Published: (2020) -
Ginsenoside Rg3 Mitigates Atherosclerosis Progression in Diabetic apoE-/- Mice by Skewing Macrophages to the M2 Phenotype
by: Mengqi Guo, et al.
Published: (2018) -
Mitigating Doxorubicin-Induced Cardiotoxicity through Quercetin Intervention: An Experimental Study in Rats
by: Patricia Lorena Dulf, et al.
Published: (2024) -
Doxorubicin Cardiotoxicity: An Update Regarding the Mechanism of Toxicity and Mitigation Strategies of Bee Propolis
by: Hodhaifa Abdul Mohsin, et al.
Published: (2023)